Cordis has announced George Adams as chief medical officer.
“We are delighted to have Dr Adams join our team as we continue to build the new Cordis,” said CEO Shar Matin. “His depth of expertise in the treatment of both complex coronary and peripheral vascular disease will play a vital role in furthering our mission to improve patient care at pace with cost-effective, differentiated solutions that build on our legacy of innovation.”
Adams is globally recognised for his expertise in the treatment of peripheral vascular disease in patients with chronic limb-threatening ischaemia (CLTI) and treatment of coronary artery disease in patients with acute coronary syndromes, a Cordis press release details. He is involved in the development of regional and national systems of care for the treatment of CLTI, ST-elevation myocardial infarction (STEMI), and management of complex coronary and peripheral vascular disease. He has a well-established network of peers and associates who are viewed as key opinion leaders within the global cardiovascular community.
“It is with great honour and excitement that I join the Cordis team as chief medical officer,” said Adams. “I look forward to playing a role in reinvigorating an incredible 62-year legacy. I am grateful to be a part of the future that Cordis is building with integrity and a vision for innovation.”
